Wang, X., Liu, Y., Liu, W., Zhang, Y., Guo, F., Zhang, L., . . . Wu, R. (2018). Ubenimex, an APN inhibitor, could serve as an anti-tumor drug in RT112 and 5637 cells by operating in an Akt-associated manner. Mol Med Rep.

Wang, Xiaoqing, Yang Liu, Wei Liu, Yongfei Zhang, Feng Guo, Lijuan Zhang, Mingyu Cui, Shuai Liu, et Rongde Wu. "Ubenimex, an APN Inhibitor, Could Serve As an Anti-tumor Drug in RT112 and 5637 Cells By Operating in an Akt-associated Manner." Mol Med Rep 2018.

Wang, Xiaoqing, et al. "Ubenimex, an APN Inhibitor, Could Serve As an Anti-tumor Drug in RT112 and 5637 Cells By Operating in an Akt-associated Manner." Mol Med Rep 2018.